Valproate Sodium is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Valproate Sodium.
Product ID | 63323-494_379dfe33-4ad2-4a1f-9c77-9ded195c87d4 |
NDC | 63323-494 |
Product Type | Human Prescription Drug |
Proprietary Name | Valproate Sodium |
Generic Name | Valproate Sodium |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2003-08-18 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA076539 |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | VALPROATE SODIUM |
Active Ingredient Strength | 100 mg/mL |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2003-08-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA076539 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2003-08-18 |
Marketing Category | ANDA |
Application Number | ANDA076539 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-10-03 |
Marketing Category | ANDA |
Application Number | ANDA076539 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2003-08-18 |
Marketing Category | ANDA |
Application Number | ANDA076539 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-06-11 |
Ingredient | Strength |
---|---|
VALPROATE SODIUM | 100 mg/mL |
SPL SET ID: | c572ece7-03d3-4c2a-aeb5-61f2023b28ea |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9637 | Valproate Sodium | Valproate Sodium |
0143-9785 | Valproate Sodium | Valproate Sodium |
63323-494 | Valproate Sodium | VALPROATE SODIUM |
70860-784 | Valproate Sodium | valproate sodium |
0074-1564 | Depacon | Valproate Sodium |